Validity of Smart Cap and Smart Sweat Patch

November 10, 2022 updated by: PepsiCo Global R&D

Validity of a Smart Cap in Measuring Fluid Intake and a Smart Sweat Patch in Measuring Sweat Rate and Sweat Chloride Concentration During Exercise

The main objectives are to determine the validity of a Smart Cap in measuring fluid intake during running and fitness exercise and the validity of a Smart Sweat Patch in measuring sweat rate and sweat chloride concentration during outdoor cycling, running, and fitness exercise. A secondary objective is to compare regional sweating rate and sweat electrolyte concentrations (sodium, chloride, and potassium) on contralateral arms with vs. without tattoos.

Study Overview

Study Type

Interventional

Enrollment (Actual)

173

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Barrington, Illinois, United States, 60010
        • Gatorade Sports Science Institute (GSSI), 617 West Main Street
      • Chicago, Illinois, United States, 60601
        • Grant Park, 337 E Randolph St
      • Deer Park, Illinois, United States, 60010
        • Cuba Marsh Forest Preserve, 24205 Cuba Rd

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject is male or female
  • Subject is 16-65 years of age
  • Subject is moderately-trained (participates in regular outdoor fitness (~1 h), cycling (1-2 h), or running (0.5-1 h) sessions ≥2x per week)
  • Subject is participating in an instructor-led fitness session, typical training run, or group bicycle ride

Exclusion Criteria:

  • Subject is pregnant
  • Subject is a smoker
  • Subject is taking a medication or oral supplement that could interfere with study results
  • Subject has an allergy to adhesives (e.g., experiences rash reactions to typical adhesive bandages)
  • Subject has ≥ 2 cardiovascular risk factors as assessed on the General Health History Questionnaire
  • Subject has participated in a clinical trial within past 30 days
  • Subject has participated in any PepsiCo trial within past 6 months
  • Subject has a condition the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk
  • Subject is employed by, or has a parent, guardian or other immediate family member employed by, a company that manufactures any products that compete with any Gatorade products. If subject is unsure if a company would be considered a competitor to Gatorade they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Smart sweat patch for sweat rate and sweat chloride concentration
Epidermal microfluidic patch that is a flexible 27 cm2 platform with an adhesive backing that collects sweat through a skin-facing inlet port. Custom software uses the smartphone camera to capture and analyze the microfluidic patch.
Regional contralateral forearm patch
Placebo Comparator: Reference sweat patch for sweat rate and sweat electrolytes
Regional absorbent patch technique for sweat rate (gravimetry) and electrolytes (sodium, potassium, chloride) by ion chromatography
Regional contralateral forearm patch
Experimental: Smart Cap bottle fluid measurement
Fluid level sensor integrated into the squeeze bottle cap measures the amount of fluid remaining in the bottle via light reflection
Bottle cap
Other: Reference method bottle fluid measurement
Scale weight of bottle (gravimetry method) for Smart Cap bottles (running and fitness subjects) and non-Smart Cap bottles (cyclists)
Bottle weight

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fluid intake
Time Frame: Change from baseline to up to 1 hour of exercise
Smart Cap (sensor) versus Reference method (bottle weight)
Change from baseline to up to 1 hour of exercise
Regional sweating rate
Time Frame: Change from baseline to up to 2 hours of exercise
Sweat Patch versus Reference patch method
Change from baseline to up to 2 hours of exercise
Regional sweat chloride concentration
Time Frame: Change from baseline to up to 2 hours of exercise
Sweat Patch versus Reference patch method
Change from baseline to up to 2 hours of exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Regional sweating rate with versus without tattoos
Time Frame: Change from baseline to up to 2 hours of exercise
Reference sweat patch method
Change from baseline to up to 2 hours of exercise
Regional sweat sodium and potassium with versus without tattoos
Time Frame: Change from baseline to up to 2 hours of exercise
Reference sweat patch method
Change from baseline to up to 2 hours of exercise
Whole body sweat rate
Time Frame: Body mass change from baseline to up to 2 hours of exercise
Scale weight
Body mass change from baseline to up to 2 hours of exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lindsay Baker, PhD, PepsiCo Global R&D, Gatorade Sports Science Institute (GSSI)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 8, 2021

Primary Completion (Actual)

August 25, 2022

Study Completion (Actual)

August 25, 2022

Study Registration Dates

First Submitted

June 3, 2021

First Submitted That Met QC Criteria

June 3, 2021

First Posted (Actual)

June 9, 2021

Study Record Updates

Last Update Posted (Actual)

November 14, 2022

Last Update Submitted That Met QC Criteria

November 10, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PEP-2104

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fluid Intake in Athletes

3
Subscribe